Laurel Wealth Planning LLC Abb Vie Inc. Transaction History

Laurel Wealth Planning LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $180,276 - $205,408	1,128 New	1,128 $205,000
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $21,257 - $24,481	-147 Reduced 10.27%	1,285 $205,000
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $30,964 - $39,366	-225 Reduced 13.58%	1,432 $219,000
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $197,969 - $245,625	1,500 Added 955.41%	1,657 $269,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 175.44%	157 $17,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $4,587 - $6,194	57 New	57 $6,000

3,697

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Laurel Wealth Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Planning LLC with notifications on news.